Clear Labs Raises $21M Series B2 to Expand Clear Safety, World’s Only Automated NGS Platform for Routine Pathogen Testing

After recently raising additional $21M, Clear Labs has raised a total of $45M to date from Menlo Ventures, Khosla Ventures, Wing Venture Capital, and others. Clear Labs claims to be the only automated and intelligent NGS (Next Generation Sequencing) platform built specifically for food safety testing. The company’s main food safety product is a high-volume testing for Salmonella. Clear Lab expects to add additional pathogens and software features in 2019. The company is currently conducting customer evaluations in preparation for general availability. The company enrolled companies constituting 90% of the U.S. poultry market, 85% of the pet food market, and 50% of the U.S.’s third-party service labs. Clear Safety combines state-of-the-art NGS sequencing, advanced microbiology, robotic automation, data science, and software analytics to significantly lower the costs of pathogen testing while achieving 99.9% accuracy. The NGS platform collects hundreds of millions of data points per analysis that can be used to learn everything about a pathogen in a single test. This data also serves as the foundation for new applications from predictive risk assessment to nutrigenomics to new product development. Since its founding in 2014, the company has built the world’s largest food genomics database, which is comprised of millions of entries. Clear Labs has over 40 customers globally, including many of the leading food brands and service labs around the world. @ https://www.prweb.com/releases/clear_labs_raises_21m_series_b2_to_expand_clear_safety_worlds_only_automated_ngs_platform_for_routine_pathogen_testing/prweb15878205.htm
Clear Labs Raises $21M Series B2 to Expand Clear Safety, World’s Only Automated NGS Platform for Routine Pathogen Testing

Menlo Park, CA (PRWEB) October 30, 2018 — Clear Labs, the only automated and intelligent NGS platform purpose-built for food safety testing, today announced

No comments

Leave a Reply